{"id":"https://openalex.org/W21740694","doi":null,"title":"Paclitaxel (Taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines.","display_name":"Paclitaxel (Taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines.","alternate_titles":[],"publication_year":1994,"publication_date":"1994-10-01","ids":{"openalex":"https://openalex.org/W21740694","mag":"21740694","pmid":"https://pubmed.ncbi.nlm.nih.gov/7939759"},"language":"en","primary_location":{"id":"pmid:7939759","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7939759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W21740694"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058537459","display_name":"Luca Gianni","orcid":"https://orcid.org/0000-0002-2372-9625","observed_orcids":["https://orcid.org/0000-0002-2372-9625"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"L Gianni","raw_affiliation_strings":["Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012144681","display_name":"Giuseppe Capri","orcid":"https://orcid.org/0000-0003-4260-0349","observed_orcids":["https://orcid.org/0000-0003-4260-0349"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Capri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038355731","display_name":"Elisabetta Munzone","orcid":"https://orcid.org/0000-0003-3371-3878","observed_orcids":["https://orcid.org/0000-0003-3371-3878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Munzone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5015070323","display_name":"Manuela Straneo","orcid":"https://orcid.org/0000-0002-2464-1633","observed_orcids":["https://orcid.org/0000-0002-2464-1633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Straneo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4516,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.90185215,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"5 Suppl 8","first_page":"29","last_page":"33"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.8600000143051147},{"id":"https://openalex.org/keywords/anthracycline-resistance","display_name":"anthracycline resistance","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chemotherapy-efficacy","display_name":"chemotherapy efficacy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6890000104904175},{"id":"https://openalex.org/keywords/alopecia","display_name":"hair loss","score":0.9179999828338623},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6019999980926514},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.5849999785423279},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9495540857315063},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.9058999419212341},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8578380346298218},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7416966557502747},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.7091283202171326},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6623371839523315},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5913190841674805},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.502823531627655},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4998915195465088},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48090243339538574},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4509911835193634},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4261058568954468},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4108770191669464},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34668537974357605},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3289126753807068},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31344175338745117}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000505","descriptor_name":"Alopecia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7939759","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7939759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Clinical Trial"},{"id":"mag:21740694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7939759","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2006804215","https://openalex.org/W2109815554","https://openalex.org/W2438522759","https://openalex.org/W2015570563","https://openalex.org/W2417415918","https://openalex.org/W1570622628","https://openalex.org/W2982501661","https://openalex.org/W2112255150","https://openalex.org/W2349047486","https://openalex.org/W2357856194"],"abstract_inverted_index":{"We":[0,120],"assessed":[1],"the":[2,35,51,112,148],"efficacy":[3],"of":[4,37,63,66,87,111,117,153],"paclitaxel":[5,96,123,154],"(Taxol;":[6],"Bristol-Myers":[7],"Squibb":[8],"Company,":[9],"Princeton,":[10],"NJ)":[11],"when":[12],"administered":[13,30,140],"by":[14,141],"3-hour":[15,142],"intravenous":[16],"infusion":[17,143],"in":[18,104,126,155],"15":[19],"patients":[20,129],"with":[21,95,144],"advanced":[22,156],"breast":[23,127,157],"cancer":[24,128,158],"resistant":[25,131],"to":[26,42,56,70,132],"anthracyclines.":[27],"Paclitaxel":[28,73],"was":[29,53],"at":[31],"175":[32],"mg/m2.":[33,58],"In":[34],"event":[36],"severe":[38],"toxicity,":[39],"dose":[40,52],"reductions":[41],"150":[43],"or":[44],"125":[45],"mg/m2":[46],"could":[47],"be":[48,138,160],"made;":[49],"otherwise,":[50],"subsequently":[54],"increased":[55],"200":[57],"Patients":[59],"received":[60],"a":[61],"median":[62],"five":[64],"cycles":[65],"treatment":[67],"(range,":[68],"one":[69],"nine":[71],"cycles).":[72],"induced":[74],"three":[75],"complete":[76],"responses":[77],"and":[78,100,109,134],"four":[79],"partial":[80],"responses,":[81],"for":[82],"an":[83],"overall":[84],"response":[85],"rate":[86],"47%.":[88],"The":[89,107],"most":[90],"frequently":[91],"observed":[92,113],"toxicities":[93,114],"associated":[94],"administration":[97],"were":[98,115],"neutropenia":[99],"alopecia,":[101],"which":[102],"occurred":[103],"all":[105],"patients.":[106],"frequency":[108],"severity":[110],"never":[116],"clinical":[118],"concern.":[119],"conclude":[121],"that":[122,135],"is":[124],"active":[125],"clinically":[130],"anthracyclines":[133],"it":[136],"can":[137],"safely":[139],"standard":[145],"premedication.":[146],"Considering":[147],"good":[149],"tolerability,":[150],"higher":[151],"doses":[152],"should":[159],"explored.":[161]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W21740694","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
